A PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF STAGE 1 SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引:311
|
作者
DELGADO, G
BUNDY, BN
FOWLER, WC
STEHMAN, FB
SEVIN, B
CREASMAN, WT
MAJOR, F
DISAIA, P
ZAINO, R
机构
[1] UNIV N CAROLINA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,CHAPEL HILL,NC 27514
[2] INDIANA UNIV,MED CTR,DEPT OBSTET & GYNECOL,GYNECOL ONCOL SECT,INDIANAPOLIS,IN 46202
[3] UNIV MIAMI,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,MIAMI,FL 33152
[4] DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DURHAM,NC 27710
[5] UNIV COLORADO,HLTH SCI CTR,DEPT OBSTET & GYNECOL,DENVER,CO 80262
[6] DENVER GEN HOSP,GYNECOL TUMOR SERV,DENVER,CO 80204
[7] UNIV CALIF IRVINE,COLL MED,DEPT OBSTET & GYNECOL,IRVINE,CA 92717
[8] PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT PATHOL,HERSHEY,PA 17033
[9] ROSWELL PK MEM INST,BUFFALO,NY
关键词
D O I
10.1016/0090-8258(89)90070-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:314 / 320
页数:7
相关论文
共 50 条
  • [41] A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: A Gynecologic Oncology Group Study
    Look, KY
    Blessing, JA
    Levenback, C
    Kohler, M
    Chafe, W
    Roman, LD
    GYNECOLOGIC ONCOLOGY, 1998, 70 (03) : 334 - 338
  • [42] Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: A gynecologic oncology group study
    Rose, PG
    Blessing, JA
    Arseneau, J
    GYNECOLOGIC ONCOLOGY, 1996, 62 (01) : 100 - 102
  • [43] Phase II trial of bevacizumab in the treatment of recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    Monk, B. J.
    Sill, M. W.
    Burger, R. A.
    Gray, H. J.
    Buekers, T. E.
    Roman, L. D.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S21 - S22
  • [44] PHASE-II TRIAL OF MENOGARIL IN PATIENTS WITH SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SUTTON, GP
    BLESSING, JA
    BARRETT, RJ
    GALLUP, DG
    GYNECOLOGIC ONCOLOGY, 1994, 52 (02) : 229 - 231
  • [45] Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
    Fracasso, PM
    Blessing, JA
    Wolf, J
    Rocereto, TF
    Berek, JS
    Waggoner, S
    GYNECOLOGIC ONCOLOGY, 2003, 90 (01) : 177 - 180
  • [46] MITOXANTRONE IN THE TREATMENT OF ADVANCED VULVAR AND VAGINAL-CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    MUSS, HB
    BUNDY, BN
    CHRISTOPHERSON, WA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (02): : 142 - 144
  • [47] GROIN DISSECTION VERSUS GROIN RADIATION IN CARCINOMA OF THE VULVA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    STEHMAN, FB
    BUNDY, BN
    THOMAS, G
    VARIA, M
    OKAGAKI, T
    ROBERTS, J
    BELL, J
    HELLER, PB
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 24 (02): : 389 - 396
  • [48] Paclitaxel has moderate activity in squamous cervix cancer: A gynecologic oncology group study
    McGuire, WP
    Blessing, JA
    Moore, D
    Lentz, SS
    Photopulos, G
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 792 - 795
  • [49] HISTOPATHOLOGIC PREDICTORS OF THE BEHAVIOR OF SURGICALLY TREATED STAGE-IB SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    ZAINO, RJ
    WARD, S
    DELGADO, G
    BUNDY, B
    GORE, H
    FETTER, G
    GANJEI, P
    FRAUENHOFFER, E
    CANCER, 1992, 69 (07) : 1750 - 1758
  • [50] An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: A Gynecologic Oncology Group Study
    Look, KY
    Brunetto, VL
    ClarkePearson, DL
    Averette, HE
    Major, FJ
    Alvarez, RD
    Homesley, HD
    Zaino, RJ
    GYNECOLOGIC ONCOLOGY, 1996, 63 (03) : 304 - 311